» Articles » PMID: 2567032

Yawning and Suppression of Exploration in Amphetamine-treated Rats, Incompatibility with the Autoreceptor Hypothesis

Overview
Specialty Pharmacology
Date 1989 Jan 1
PMID 2567032
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The hypothesis that yawning and suppression of exploration, induced by low doses of dopamine agonists, are mediated by stimulation of dopamine autoreceptors was tested by studying the influence of amphetamine on these behavioural models and on extracellular levels of dopamine sampled by microdialysis. Behaviour was measured in a holeboard apparatus. A low dose of amphetamine (0.2 mg/kg) caused slight activation of habituated rats. The same dose of amphetamine completely counteracted the decrease in extracellular dopamine levels caused by pergolide (0.02 mg/kg) and, instead, elevated the dopamine levels to 300% above baseline. The same or higher doses of amphetamine (0.5-1.0 mg/kg) did not completely antagonise suppression of exploration or yawning induced by apomorphine (0.05 mg/kg) or pergolide (0.02 mg/kg). The results suggest that both yawning and suppression of exploration induced by low doses of dopamine agonists are not mediated by dopamine autoreceptors, since these behaviours could be elicited when the extracellular levels of dopamine were elevated above baseline. The alternative hypothesis that these behaviours are mediated by sensitive post-synaptic receptors is suggested. It was also found that combined treatment with SCH 23390 (0.05 mg/kg) and amphetamine (2 mg/kg) induced yawning, which further supports the new hypothesis.

Citing Articles

Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.

Mattingly B, Rowlett J, Lovell G Psychopharmacology (Berl). 1993; 110(3):320-6.

PMID: 7831425 DOI: 10.1007/BF02251287.


Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.

KROPF W, Kuschinsky K, Krieglstein J Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(6 Pt 2):718-25.

PMID: 2699354 DOI: 10.1007/BF00169680.


Effects of single and repeated treatment with antidepressants on apomorphine-induced yawning in the rat: the implication of alpha-1 adrenergic mechanisms in the D-2 receptor function.

Delini-Stula A, Hunn C Psychopharmacology (Berl). 1990; 101(1):62-6.

PMID: 1971448 DOI: 10.1007/BF02253719.


Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.

Yamada K, Nagashima M, Kimura H, Matsumoto S, Furukawa T Psychopharmacology (Berl). 1990; 100(2):141-4.

PMID: 1968276 DOI: 10.1007/BF02244396.


Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study.

Stahle L, Collin A, Ungerstedt U Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(2):136-40.

PMID: 1700307 DOI: 10.1007/BF00166955.


References
1.
Longoni R, Spina L, Di Chiara G . Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats. Eur J Pharmacol. 1987; 134(2):163-73. DOI: 10.1016/0014-2999(87)90162-2. View

2.
Strombom U . Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn Schmiedebergs Arch Pharmacol. 1976; 292(2):167-76. DOI: 10.1007/BF00498588. View

3.
Starke K, Reimann W, Zumstein A, Hertting G . Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1978; 305(1):27-36. DOI: 10.1007/BF00497003. View

4.
Mogilnicka E, Klimek V . Drugs affecting dopamine neurons and yawning behavior. Pharmacol Biochem Behav. 1977; 7(4):303-5. DOI: 10.1016/0091-3057(77)90224-6. View

5.
Smith R, Tamminga C, Davis J . Effect of apomorphine on schizophrenic symptoms. J Neural Transm. 1977; 40(2):171-6. DOI: 10.1007/BF01250567. View